Skip to contentR
Reflect Scientific, Inc.
R
RSCFReflect Scientific, Inc. Q2 2024 · 10-Q
Revenue$590.07K$590.07K+374.4% vs Q2 2023 Net Income$108.99K$108.99KN/M vs Q2 2023 EPS Diluted$0.00$0.00— vs Q2 2023 Gross Profit$358,557+492.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Reflect Scientific, Inc. · CIK 1103090 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,272−98.4% Margins · derivedGross margin60.8%+12.1 pt vs Q2 2023
Operating margin16.7%+162.0 pt vs Q2 2023
Net margin18.5%+164.1 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 13, 2024 · 44 d after period end